https://www.selleckchem.com/pr....oducts/blasticidin-s
02, 11.17), and effect size 0.6. Secondary endpoints were statistically similar. Critically ill medical patients who require an insulin infusion have a reduced insulin requirement when fed intermittently, whereas dysglycemia metrics are not adversely affected. A larger clinical study is required to confirm these findings. Critically ill medical patients who require an insulin infusion have a reduced insulin requirement when fed intermittently, whereas dysglycemia metrics are not adversely affected. A larger clinical study is r
Like
Comment
Share
